Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200146821> ?p ?o ?g. }
- W4200146821 endingPage "101043" @default.
- W4200146821 startingPage "101043" @default.
- W4200146821 abstract "In order to combat an evolving, multidimensional disease such as cancer, research has been aimed at synthesizing more efficient and effective versions of popular chemotherapeutic drugs. Despite these efforts, there remains a necessity for the development of suitable delivery vehicles that can both harness the chemotherapeutic effects meanwhile reducing some of the known issues when using these drugs such as unwanted side-effects, acquired drug resistance, and associated difficulties with drug delivery. Synthetic drug discovery approaches focusing on modification of the native structure of these chemotherapeutic drugs often face challenges such as loss of efficacy, as well as a potential worsening of side-effects. Synthetic chemists are then left with increasingly narrow choices for possible chemistry they could implement to achieve the desired therapy. The emergence of targeted therapies using controlled-release nanomaterials can provide many opportunities for conventional chemotherapeutic drugs to be delivered to specific target sites, ultimately leading to reduced side-effects and improved efficacy. Logically, it may prove advantageous to consider nano-delivery systems as a likely candidate for circumventing some of the barriers associated with creating viable drug therapies. In this review, we summarize controlled release nanoformulations of the three most widely used and approved chemotherapeutics, doxorubicin, paclitaxel, and cisplatin as an alternative therapeutic approach against different cancer types." @default.
- W4200146821 created "2021-12-31" @default.
- W4200146821 creator A5016587556 @default.
- W4200146821 creator A5024358551 @default.
- W4200146821 creator A5042051993 @default.
- W4200146821 creator A5052296080 @default.
- W4200146821 creator A5061323179 @default.
- W4200146821 date "2022-02-01" @default.
- W4200146821 modified "2023-10-12" @default.
- W4200146821 title "Controlled release nanoplatforms for three commonly used chemotherapeutics" @default.
- W4200146821 cites W1434886714 @default.
- W4200146821 cites W1543790510 @default.
- W4200146821 cites W1843302206 @default.
- W4200146821 cites W1871308790 @default.
- W4200146821 cites W1964957951 @default.
- W4200146821 cites W1970168078 @default.
- W4200146821 cites W1972992205 @default.
- W4200146821 cites W1976041621 @default.
- W4200146821 cites W1993456710 @default.
- W4200146821 cites W1996523853 @default.
- W4200146821 cites W2001191004 @default.
- W4200146821 cites W2007747310 @default.
- W4200146821 cites W2008791357 @default.
- W4200146821 cites W2011030869 @default.
- W4200146821 cites W2028156849 @default.
- W4200146821 cites W2028211453 @default.
- W4200146821 cites W2031561431 @default.
- W4200146821 cites W2037571189 @default.
- W4200146821 cites W2041377837 @default.
- W4200146821 cites W2051787604 @default.
- W4200146821 cites W2064093384 @default.
- W4200146821 cites W2068577449 @default.
- W4200146821 cites W2086681374 @default.
- W4200146821 cites W2095907514 @default.
- W4200146821 cites W2102449174 @default.
- W4200146821 cites W2102886707 @default.
- W4200146821 cites W2103358944 @default.
- W4200146821 cites W2105553762 @default.
- W4200146821 cites W2105681978 @default.
- W4200146821 cites W2107436374 @default.
- W4200146821 cites W2107660675 @default.
- W4200146821 cites W2108471741 @default.
- W4200146821 cites W2112927879 @default.
- W4200146821 cites W2116118767 @default.
- W4200146821 cites W2117692326 @default.
- W4200146821 cites W2125107262 @default.
- W4200146821 cites W2138869932 @default.
- W4200146821 cites W2142580180 @default.
- W4200146821 cites W2146757262 @default.
- W4200146821 cites W2159241628 @default.
- W4200146821 cites W2163737596 @default.
- W4200146821 cites W2167455663 @default.
- W4200146821 cites W2170726961 @default.
- W4200146821 cites W2252358402 @default.
- W4200146821 cites W2323860656 @default.
- W4200146821 cites W2344598639 @default.
- W4200146821 cites W2415809183 @default.
- W4200146821 cites W2554773181 @default.
- W4200146821 cites W2584601959 @default.
- W4200146821 cites W2612502936 @default.
- W4200146821 cites W2766971652 @default.
- W4200146821 cites W2890167612 @default.
- W4200146821 cites W2890809113 @default.
- W4200146821 cites W2894569726 @default.
- W4200146821 cites W2896144504 @default.
- W4200146821 cites W2901027643 @default.
- W4200146821 cites W2901249376 @default.
- W4200146821 cites W2910036358 @default.
- W4200146821 cites W2928131335 @default.
- W4200146821 cites W2943106036 @default.
- W4200146821 cites W2952165521 @default.
- W4200146821 cites W2969822417 @default.
- W4200146821 cites W2970329262 @default.
- W4200146821 cites W2977565522 @default.
- W4200146821 cites W2992783948 @default.
- W4200146821 cites W3007109089 @default.
- W4200146821 cites W3036620193 @default.
- W4200146821 cites W3109746568 @default.
- W4200146821 cites W3129058300 @default.
- W4200146821 cites W3150554748 @default.
- W4200146821 doi "https://doi.org/10.1016/j.mam.2021.101043" @default.
- W4200146821 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34920863" @default.
- W4200146821 hasPublicationYear "2022" @default.
- W4200146821 type Work @default.
- W4200146821 citedByCount "7" @default.
- W4200146821 countsByYear W42001468212022 @default.
- W4200146821 countsByYear W42001468212023 @default.
- W4200146821 crossrefType "journal-article" @default.
- W4200146821 hasAuthorship W4200146821A5016587556 @default.
- W4200146821 hasAuthorship W4200146821A5024358551 @default.
- W4200146821 hasAuthorship W4200146821A5042051993 @default.
- W4200146821 hasAuthorship W4200146821A5052296080 @default.
- W4200146821 hasAuthorship W4200146821A5061323179 @default.
- W4200146821 hasBestOaLocation W42001468212 @default.
- W4200146821 hasConcept C112930515 @default.
- W4200146821 hasConcept C121608353 @default.
- W4200146821 hasConcept C126322002 @default.
- W4200146821 hasConcept C171250308 @default.